119 related articles for article (PubMed ID: 18051786)
1. [The clinical significance of mast cell tryptase in bronchial alveolar lavage fluid in interstitial lung diseases].
Kawatani K; Kondo M; Tamaoki J; Tagaya E; Nagai A
Nihon Kokyuki Gakkai Zasshi; 2007 Nov; 45(11):848-55. PubMed ID: 18051786
[TBL] [Abstract][Full Text] [Related]
2. S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis.
Hara A; Sakamoto N; Ishimatsu Y; Kakugawa T; Nakashima S; Hara S; Adachi M; Fujita H; Mukae H; Kohno S
Respir Med; 2012 Apr; 106(4):571-80. PubMed ID: 22209187
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.
Suga M; Iyonaga K; Ichiyasu H; Saita N; Yamasaki H; Ando M
Eur Respir J; 1999 Aug; 14(2):376-82. PubMed ID: 10515417
[TBL] [Abstract][Full Text] [Related]
4. Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases.
Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Skibova J; Striz I
Scand J Immunol; 2009 Mar; 69(3):268-74. PubMed ID: 19281539
[TBL] [Abstract][Full Text] [Related]
5. [Mast cells in bronchoalveolar lavage fluid of patients with interstitial lung diseases].
Schildge J; Klar B; Hardung-Backes M
Pneumologie; 2003 Apr; 57(4):202-7. PubMed ID: 12690558
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of tryptase in bronchoalveolar lavage fluid from patients with sarcoidosis.
Eklund A; van Hage-Hamsten M; Sköld CM; Johansson SG
Sarcoidosis; 1993 Mar; 10(1):12-7. PubMed ID: 8134709
[TBL] [Abstract][Full Text] [Related]
7. Elevated matrilysin levels in bronchoalveolar lavage fluid do not distinguish idiopathic pulmonary fibrosis from other interstitial lung diseases.
Vuorinen K; Myllärniemi M; Lammi L; Piirilä P; Rytilä P; Salmenkivi K; Kinnula VL
APMIS; 2007 Aug; 115(8):969-75. PubMed ID: 17696954
[TBL] [Abstract][Full Text] [Related]
8. Comparison of BALF concentrations of ENA-78 and IP10 in patients with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia.
Nakayama S; Mukae H; Ishii H; Kakugawa T; Sugiyama K; Sakamoto N; Fujii T; Kadota J; Kohno S
Respir Med; 2005 Sep; 99(9):1145-51. PubMed ID: 16085216
[TBL] [Abstract][Full Text] [Related]
9. [A study on enzymatic activities of bronchoalveolar lavage fluid in patients with interstitial lung diseases].
Zheng J; Jia Y; Zhou K
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Feb; 21(2):91-3. PubMed ID: 11263392
[TBL] [Abstract][Full Text] [Related]
10. Elevated BALF concentrations of alpha- and beta-defensins in patients with pulmonary alveolar proteinosis.
Mukae H; Ishimoto H; Yanagi S; Ishii H; Nakayama S; Ashitani J; Nakazato M; Kohno S
Respir Med; 2007 Apr; 101(4):715-21. PubMed ID: 17000097
[TBL] [Abstract][Full Text] [Related]
11. Macrophage inflammatory protein-1 alpha expression in interstitial lung disease.
Standiford TJ; Rolfe MW; Kunkel SL; Lynch JP; Burdick MD; Gilbert AR; Orringer MB; Whyte RI; Strieter RM
J Immunol; 1993 Sep; 151(5):2852-63. PubMed ID: 8360496
[TBL] [Abstract][Full Text] [Related]
12. [Interstitial pneumonia associated with collagen vascular diseases: histological findings, and cells in bronchoalveolar lavage fluid].
Nagai S; Satake N; Kitaichi M; Izumi T
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Dec; 33 Suppl():258-63. PubMed ID: 8752516
[TBL] [Abstract][Full Text] [Related]
13. Protein C anticoagulant system in patients with interstitial lung disease.
Kobayashi H; Gabazza EC; Taguchi O; Wada H; Takeya H; Nishioka J; Yasui H; Kobayashi T; Hataji O; Suzuki K; Adachi Y
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1850-4. PubMed ID: 9620917
[TBL] [Abstract][Full Text] [Related]
14. Cytokine gene polymorphisms and BALF cytokine levels in interstitial lung diseases.
Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Striz I
Respir Med; 2009 May; 103(5):773-9. PubMed ID: 19117745
[TBL] [Abstract][Full Text] [Related]
15. Clinical importance of bronchoalveolar lavage fluid and blood cytokines, surfactant protein D, and Kerbs von Lungren 6 antigen in idiopathic pulmonary alveolar proteinosis.
Lin FC; Chen YC; Chang SC
Mayo Clin Proc; 2008 Dec; 83(12):1344-9. PubMed ID: 19046553
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of bronchoalveolar lavage fluids from nonspecific interstitial pneumonia and from ordinary interstitial pneumonia].
Sakamoto N; Mukae H; Kakugawa T; Nagata T; Kaida H; Ishii H; Abe K; Kadota J; Matsukura S; Kohno S
Nihon Kokyuki Gakkai Zasshi; 2002 Jul; 40(7):564-8. PubMed ID: 12382419
[TBL] [Abstract][Full Text] [Related]
17. Can circulating interleukin-18 differentiate between sarcoidosis and idiopathic pulmonary fibrosis?
Liu DH; Cui W; Chen Q; Huang CM
Scand J Clin Lab Invest; 2011 Nov; 71(7):593-7. PubMed ID: 21834618
[TBL] [Abstract][Full Text] [Related]
18. Bronchoalveolar lavage fluid angiotensin-converting enzyme in interstitial lung diseases.
Specks U; Martin WJ; Rohrbach MS
Am Rev Respir Dis; 1990 Jan; 141(1):117-23. PubMed ID: 2153351
[TBL] [Abstract][Full Text] [Related]
19. Expression of RANTES by bronchoalveolar lavage cells in nonsmoking patients with interstitial lung diseases.
Kodama N; Yamaguchi E; Hizawa N; Furuya K; Kojima J; Oguri M; Takahashi T; Kawakami Y
Am J Respir Cell Mol Biol; 1998 Apr; 18(4):526-31. PubMed ID: 9533940
[TBL] [Abstract][Full Text] [Related]
20. [Extracellular components of broncho-alveolar lavage fluid (BALF) as markers of interstitial pulmonary disease activity. II. Phospholipid concentration].
Zielonka TM; Wałajtys-Rode E; Jasińska R; Chazan R; Droszcz W
Przegl Lek; 1998; 55(12):654-8. PubMed ID: 10354716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
